0001594864-15-000001.txt : 20150714 0001594864-15-000001.hdr.sgml : 20150714 20150714165211 ACCESSION NUMBER: 0001594864-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20150714 DATE AS OF CHANGE: 20150714 EFFECTIVENESS DATE: 20150714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-243722 FILM NUMBER: 15987746 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0707 D LIVE 0001594864 Juno Therapeutics, Inc. 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA WASHINGTON 98109 (206) 582-1600 DELAWARE FC Therapeutics, Inc. None Corporation true 2013 Hans Bishop 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Steven Harr 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Mark Frohlich 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Promoter Hyam Levitsky 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Bernard J. Cassidy 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Hal Barron 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Anthony Evnin 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Richard Klausner 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Robert Nelsen 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Howard Pien 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Marc Tessier-Lavigne 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Mary Agnes Wilderotter 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Biotechnology No Revenues 06c false 2015-06-29 true true true true false 0 Indefinite 849803496 Indefinite See the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 29, 2015. false 1 0 0 0 false Juno Therapeutics, Inc. /s/ Bernard J. Cassidy Bernard J. Cassidy General Counsel & Secretary 2015-07-14